Tag: Alexion

A total of 12 posts are filed under Alexion
Alexion, UConn Partner to Fight Rare Diseases
New Haven-based bio-pharmaceutical company Alexion Pharmaceuticals is working with the University of Connecticut to create a fund to support… Continue Reading
Rare Disease Report: FDA Approves Alexion’s Kanuma for LAL Deficiency
The FDA approved Alexion’s Kanuma (sebelipase alfa) to treat patients with lysosomal acid lipase (LAL) deficiency. Kanuma is an enzyme… Continue Reading
Global Genes to Host Fourth Annual Tribute to Champions of Hope Gala and Patient Advocacy Summit
On September 26th, 2015, over 650 attendees from across the globe will gather at the Hyatt Regency Resort and Spa in Huntington Beach, CA,… Continue Reading
Atypical Hemolytics Uremic Syndrome (aHUS) Parents Attend Meetups
Fourteen meetups for Atypical Hemolytic Uremic Syndrome (aHUS) will take place this year. There is an average of about 30 attendees per… Continue Reading
Just Like Me: Rare Patients Talk Face-to-Face for the First Time at aHUs Meetups
They’re never in the waiting room. You’d be shocked to meet one in the emergency room. You search and you wait and you wonder if… Continue Reading
Forbes Reporters: How A $440,000 Drug Is Turning Alexion Into Biotech’s New Innovation Powerhouse
The pharmaceutical business is not kind to entrepreneurs. It takes more than a decade and hundreds of millions of dollars in venture capital… Continue Reading
Alexion and Cincinnati Children’s Launch Rare Disease Innovation Fund
Alexion Pharmaceuticals, Inc. and Cincinnati Children’s Hospital Medical Center today announced the establishment of a collaboration and… Continue Reading